Patent US3621099A successfully refreshed from Google Patents.
US3621099A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic compositions and methods for stimulating the central nervous system
Assignee: Individual
•
Filing: 1969-03-05
•
Granted: 1971-11-16
•
Expires: 1989-03-05
Abstract
Abstract Pharmaceutical compositions which are stimulating and which contain a pharmaceutical excipient and an alkyl-substituted urazole. The process of causing stimulation by administering the composition.
Inventors
- 👤 Charles R Jacobson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 10:13
CPC Classifications
C; C07; C07D; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/12
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
27 words
The composition of claim 1, wherein in the urazole R3 is a hydrogen atom and R1 and R2 are each alkyl of one to five carbon atoms.
Claim 2
Dependent Claim
29 words
The composition of claim 1, wherein in the urazole R3 is as defined in claim 1 and R1 and R2 are each alkyl of one to five carbon atoms.
Claim 3
Dependent Claim
17 words
The composition of claim 1 wherein the dosage unit contains 0.5- 1.0 mg. of the urazole compound.
Claim 4
Dependent Claim
47 words
The process of causing stimulation of the central nervous system comprising administering to a patient a therapeutical composition containing as central nervous system stimulating agent, in an amount sufficient but not greater than that necessary to stimulate the central nervous system, a urazole compound of the formula
Claim 5
Dependent Claim
31 words
The process of claim 5, wherein in the urazole of the administered composition, R3 is a hydrogen atom and R1 and R2 are each alkyl of one to five carbon atoms.
Claim 6
Dependent Claim
33 words
The process of claim 5, wherein in the urazole of the administered composition, R3 is as defined in claim 1 and R1 and R2 are each alkyl of one to five carbon atoms.
Claim 7
Dependent Claim
27 words
The process of claim 5 in which the therapeutical composition is administered in dosage units each of which contains at least 0.5 mg. of the urazole compound.
Claim 8
Dependent Claim
18 words
The process of claim 5 in which the dosage unit administered contains 0.5-1.0 mg. of the urazole compound.
Claim 9
Dependent Claim
20 words
The process of claim 5 wherein R1, R2 and R3 are each one alkyl of one to five carbon atoms.
References Cited (Backward Citations)
US2944060A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1974-11-15 | 1975-05-17 | 1975-11-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1978-11-15 | 1979-05-17 | 1979-11-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1982-11-15 | 1983-05-17 | 1983-11-16 | $7700.00 | Window Closed / Lapsed |